New Hampshire IV Therapy Education
As a prerequisite of this
The New Hampshire IV Therapy Education curriculum has been designed to fulfill the New Hampshire Board of Nursing’s education components required for the Licensed Practical Nurse to practice infusion therapy. The New Hampshire Board of Nursing has delineated very specific content to be included in the LPN infusion education curriculum and specifics may be viewed in the New Hampshire BON Organizational Rules, Chapter 604.07 Curriculum. This comprehensive online education program meets the New Hampshire Board of Nursing IV Therapy requirements for LPN’s, as well as, provides an excellent refresher course for the Registered Nurse or as a primer for new RN’s. The New Hampshire BON Organizational Rules, in Chapter 604.08 Participants, lists additional criteria for intravenous therapy course participants.
In early 2021, the Infusion Nurses Society (INS), recognized as the global authority in infusion therapy, released the updated Infusion Therapy Standards of Practice. The INS sets the accepted standards for infusion therapy practice for all healthcare settings. This course is based on the current best practices as defined by the Infusion Nursing Society and other governing agencies such as the CDC, and FDA.
This 32-hour continuing education course provides
Within the course content, the participant is provided a complete set of skill competency checklists for completion of the clinical portion of the course. The competency verifications are completed by a New Hampshire licensed registered nurse preceptor or educator, when guided and supported by the LPN’s facility policies. The participant is also required to register for a 4-hour skills session with New England Vascular Access (NEVA). NEVA will provide the participant with hands-on instruction and skill competency evaluations, as required by the NHBON. The purchase price of this course covers the didactic portion of the course, the 4 hour skills session with NEVA, and all IV supplies required. Facilities may purchase this course for their nurses by contacting us at support@pedagogyeducation.com.
After successful completion of the didactic portion of the online IV therapy course, you may click here to register for the skills portion of the course - please select LPN IV Therapy Course Part 2, when registering.
Have questions? Check out our FAQs page and our page, How Online IV Certification Works. If you need to purchase IV education for your staff, see our Learning Management System page for more information and instructions on how to get started.
Objectives
Section 1 - New Hampshire Legalities of Infusion Therapy
Upon completion of this section, the participant will be able to:
- List the 2 components required for the LVN to practice IV therapy in the state of New Hampshire.
- Describe delegation procedures for New Hampshire nurses.
- Explain how the Nurse Licensure Compact impacts the nurse's provision of infusion therapy.
Section 2 - Basics of Peripheral IV Therapy; Current Standards of Practice
Upon completion of this section, the participant will be able to:
- List specific measures that will protect against malpractice.
- Identify infusion related complications, causes and appropriate treatment.
- Demonstrate the correct calculation of an IV flow rate.
- Identify methods of infection control related to IV therapy.
- List the components of accurate and complete documentation of IV procedures and complications.
Section 3 - Current Practices in the Management of Central Lines
Upon completion of the section, participants should be able to:
- List reasons for use and advantages of central lines.
- List veins used for central venous device placement and proper tip position.
- Identify the various types of central lines.
- Identify symptoms and prevention of complications.
- Describe assessment criteria and documentation required for patients with central venous catheters.
Section 4 - It's All About Ports
Upon completion of this section, the participant will be able to:
- Distinguish an implanted venous port from other types of central venous access devices.
- Describe the procedure for accessing and de-accessing an implanted port.
- Describe the procedure for drawing a blood specimen from a port.
- State at least 3 potential port complications.
Section 5 - Goal: Zero Catheter Related Blood Stream Infections
Upon completion of this section, the participant will be able to:
- Identify at least three negative effects of central line related bloodstream infections.
- Identify at least two methods by which central lines become colonized.
- Identify at least three strategies to reduce the risk of CRBSI at the time of catheter insertion.
- Recognize the proper time intervals and procedures for dressing change, injection port change, and site observation.
- State the recommended methods for obtaining blood cultures for CRBSI diagnosis.
- State the recommended methods for treating CRBSI.
Section 6 - IV Push Medications
Upon completion of this section, the participant should be able to:
- Explain the difference between IV push medication administration and IV infusion medication administration .
- Recognize potential negative effects of administering IV push medications incorrectly .
- Demonstrate the proper procedures involved in the preparation and administration of IV push medications.
Section 7 - Prevention and Management of Intravenous Extravasation
Upon completion of this section, the participant will be able to:
- Distinguish the difference between an infiltration and an extravasation.
- Describe INS and ONS standards of practice related to vesicant administration.
- Discuss appropriate measures to prevent an extravasation.
- Recognize at least three classes of drug generally accepted as vesicants.
- Discuss at least four measures used to treat extravasations.
Section 8 - Hypodermoclysis
Upon completion of this section, the participant will be able to:
- Identify at least 3 factors that contribute to dehydration in the elderly.
- Define hypodermoclysis.
- Describe the advantages, disadvantages, indications, and contraindications of hypodermoclysis.
- Describe the appropriate sites, solutions, volumes and rates for hypodermoclysis.
- Describe the procedure for hypodermoclysis administration.
- State at least 3 potential complications of hypodermoclysis.
Section 9 - Intravenous Antibiotics: Antifungals
Upon completion of this section, the participant will be able to:
- Identify the indications, proper administration, and side effects of available intravenous antifungal medications.
- Explain two potential causes of antifungal resistance.
Section 10 - Intravenous Antibiotics: Antivirals
Upon completion of this section, the participant will be able to:
- Describe the mechanisms of viral infection in a human host.
- Describe the use of various intravenous antiviral delivery systems.
- Identify the indications, proper administration, and side effects of available intravenous antiviral medications.
Section 11 - Intravenous Antibiotics: ß-lactams
Upon completion of this section, the participant will be able to:
- Identify at least two actions that have increased the incidence of antibiotic resistance.
- Describe the use of various intravenous antibiotic admixture containers and delivery systems.
- Identify the classifications of intravenous beta-lactam antibiotics and medications belonging to each class.
Section 12 - Intravenous Antibiotics: Glycopeptides
Upon completion of this section, the participant will be able to:
- Identify at least two actions that have increased the incidence of antibiotic resistance.
- Describe the use of various intravenous antibiotic admixture containers and delivery systems.
- Identify the classifications of intravenous glycopeptide antibiotics and medications belonging to each class.
Section 13 - Intravenous Antibiotics: Additional Classifications
Upon completion of this section, the participant will be able to:
- Identify at least two actions that have increased the incidence of antibiotic resistance.
- Describe the use of various intravenous antibiotic admixture containers and delivery systems.
- Identify the classifications of intravenous antibiotics and medications belonging to each class.
Curriculum
Chapter 1: Nursing Regulations and State Boards of Nursing
- Boards of Nursing
- Nurse Practice Acts
- Licensure
Chapter 2: New Hampshire State Board of Nursing
- Mission
- Board Meetings
- New Hampshire Board of Nursing Bulletin
Chapter 3: New Hampshire Nurse Practice Act
- Nurse Licensure Compact
Chapter 4: New Hampshire Scope of Practice
- Licensed Practical Nurse Scope of Practice
- Registered Nurse Scope of Practice
- Advanced Practice Registered Nurse Scope of Practice
- Scope of Practice Advisories
Chapter 5: Delegation
Chapter 6: New Hampshire Rules and Advisories
- Position Statements and Advisories
Chapter 7: Legal Issues
- Regulatory Agencies and Governing Bodies
- Components of a Complete Physicians Order
- Legal Terms and Applications in Nursing
- Protective Measures for Guarding against Malpractice Lawsuits
Chapter 8: Peripheral Anatomy and Physiology
- The Vascular System: Veins, Arteries and Bone Marrow
- The Three Layers of the Vessels and Their Function
- Differentiating Arteries from Veins
- Veins used in Peripheral Intravenous Therapy for Pediatrics and Adults
- Intraosseous
- Skin: Anatomy and Physiology
Chapter 9: Psychological Needs of the IV Patient
- Age Specific Needs of Children
- Elderly Patient Needs
- Cultural Aspects
- Patients with Sensory Deficits
- Methods of Reducing Patient Anxiety
- Patient Teaching/Education
Chapter 10: Fluid and Electrolyte Balance
- Water: The Primary Fluid of the Body
- Hypovolemia - Dehydration: Assessment, Causes, Treatments
- Hypervolemia - Fluid Overload: Assessment, Causes, Treatments
- Fluid Compartments
- Electrolyte Imbalances: Assessment, Causes, Treatments
Chapter 11: pH, Osmolality, and Incompatibilities of Solutions and Medications
- pH of Intravenous Solutions and Medications
- Tonicity: Isotonic solutions, Hypotonic solutions and Hypertonic Solutions Incompatibilities
Chapter 12: Fluid Regulation
- Methods of Fluid Regulation
- Patient Considerations in Fluid Regulation
- External Factors that Affect the Rate of Flow
- Calculation of IV flow rates
Chapter 13: Infection Prevention and Safety Compliance
- Hand Hygiene
- Sharps Management
- Medical Waste Disposal
- Durable Medical Equipment Disinfection
- Standard Precautions
- Transmission-Based Precautions
Chapter 14: Vascular Visualization
- Trans-illuminator Technology
- Near Infrared Technology
- Ultrasound
Chapter 15: Site Selection and Device Placement
- Criteria for Peripheral Devices
- 3 Types of Peripheral Access And Criteria For Placement
- Special Considerations of The Specific Age Groups
- General Considerations of Short Peripheral Access
- Veins to Avoid
Chapter 16: Vascular Access Device Management
- Needleless Connectors
- Filtration
- Add-on Devices
- VAD Stabilization
- Joint Stabilization
- Site Protection
- Flushing and Locking
- Assessment, Care, and Dressing Changes
- Administration Set Changes
Chapter 17: Peripheral IV Complications
- Local Complications
- Hematoma
- Infiltration
- Extravasation
- Phlebitis
- Site Infection
- Catheter Occlusion
- MARSI
- Nerves and Nerve Damage
- Compartment Syndrome
- Systemic Complications
Chapter 18: Peripheral IV Procedures Guides and Videos
- Pre-insertion Procedures
- Peripheral IV Insertion
- Primary and Secondary Administration set-up
- IV Push Administration
- Catheter Discontinuation
Chapter 19: Peripheral IV Assessment and Documentation
- Catheter Insertion Documentation
- Catheter Removal Documentation
- Assessment, Monitoring and Documentation by Therapy
Chapter 20: Central Line Review
- Definition of a Central line
- Reasons for use of a central line
- Advantages of a central line
- Overview of Central Venous Access Devices
- Lumens
- Non‐valved and valved catheters
- Non‐tunneled catheters
- Tunneled catheters
- Implanted ports
- PICC or Peripherally Inserted Central Catheter
Chapter 21: CVAD Anatomy
- Veins used for placement of central venous access devices
- Catheter tip placement
Chapter 22: Assessment and Preparations for CVADs
- Considerations for selection of the device
- Preparations for central venous catheterization
Chapter 23: CVAD Management
- Needleless Connectors
- Filtration
- Add-On Devices
- CVAD Stabilization
- Site Protection
- Flushing and Locking
- Assessment, Care, and Dressing Changes
- Administration Set Changes
- Blood Sampling from a CVAD
Chapter 24: CVAD Procedure Guides and Videos
- Central venous catheter dressing change
- Needleless access device change
- Central venous catheter flushing
- Blood Sampling from a CVAD
Chapter 25: CVAD Complications
- Catheter-related complications
- Systemic complications
- Insertion-related complications
Chapter 26: Discontinuation of Therapy
- Removal of devices
- Central venous access device removal procedure
Chapter 27: CVAD Assessment, Documentation, and Patient Education
- Documentation of insertions, removal, infiltration or extravasations
- Assessment, monitoring, documentation by type of therapy
Chapter 28: Ports
- Port vs. Other Central Venous Access Devices
- Advantages and Disadvantages
- Indications
Chapter 29: Assessment and Preparations for Implanted Port
- Assessment Criteria for Insertion of an Implanted Port
- Preparations for Implanted Venous Port
Chapter 30: Accessing a Port
- Equipment
- Needle Choice
- Procedure
Chapter 31: De-accessing a Port
Chapter 32: Drawing Blood from a Port
Chapter 33: Port Complications
- Malpositioned catheter
- Reservoir malposition
- Catheter separation
- Catheter occlusion
- Infiltration
- Extravasation
- Site Infection
- Catheter Related Bloodstream Infection (CRBSI) or Septicemia
- Skin breakdown
Chapter 34: CRBSI - Scope of Problem
- Morbidity/mortality
- Cost
- Surveillance
Chapter 35: Catheter Insertion
- Site selection
- Sterile rechnique
- Antimicrobial impregnated catheters
Chapter 36: Catheter Site Maintenance
- Dressing
- Needleless connector
- Observation
Chapter 37: Medication Administration
- Infusate
- Administration Set
- Flushing
Chapter 38: CRBSI Diagnosis and Treatment
- Clinical Findings
- Cultures
- Treatment
Chapter 39: Introduction to IV Push
- Definition
- Indications
Chapter 40: IV Push Drugs
- Classes
- Medications
Chapter 41: IV Push Medication Administration
Chapter 42: IV Push - Assessment, Education, and Documentation
- Assessment
- Patient education
- Documentation
Chapter 43: Introduction to Extravasation
- Definitions
- Scope of the Problem
- Liability
- Standards of Practice
Chapter 44: Extravasation Prevention
Chapter 45: Vesicant Lists
- Antineoplastic Agents
- Non-cytotoxic Agents
Chapter 46: Extravasation Treatments
- Antidotes
- Administration
Chapter 47: Extravasation Documentation
Chapter 48: Dehydration and Hypodermoclysis
- Scope of Problem
- Contributing Factors
- Signs and Symptoms
- Assessment
Chapter 49: Introduction to Hypodermoclysis
- Advantages
- Disadvantage
- Indications
- Contraindications
- Use in Terminally Ill Patients
Chapter 50: Hypodermoclysis Infusion Parameters
- Sites
- Solutions
- Volume and Rate
- Hyaluronidase
Chapter 51: Hypodermoclysis Administration
- Equipment
- Procedures
Chapter 52: Hypodermoclysis Complications
- Systemic Complications
- Local Complications
Chapter 53: Communication and Documentation
Chapter 54: Introduction to Antifungals
Chapter 55: Polyene Antifungals
- Amphotericin B deoxycholate
- AmBisome®
- Abelcet®
- Amphotec®
Chapter 56: Echinocandins
- Anidulafungin
- Caspofungin
- Micafungin
Chapter 57: Azoles
- Fluconazole
- Itraconazole
- Voriconazole
- Isavuconazole
Chapter 58: Antivirals Introduction
- Mode of viral infection
- History of antiviral treatment
- Antiviral resistance
- Intravenous antiviral administration systems
Chapter 59: Acyclovir
- Indications
- Administration
- Side Effects
Chapter 60: Cidofovir
- Indications
- Administration
- Side Effects
Chapter 61: Foscarnet
- Indications
- Administration
- Side Effects
Chapter 62: Gancyclovir
- Indications
- Administration
- Side Effects
Chapter 63: Zidovudine
- Indications
- Administration
- Side Effects
Chapter 64: Peramivir
- Indications
- Administration
- Side Effects
Chapter 65: Antivirals - Antibiotic Stewardship
- Combination therapy
- New antivirals
- Adoptive Transfer of Virus-Specific T Cells
Chapter 66: Introduction to ß-lactams
- Antibiotic resistance
- Intravenous antibiotic administration systems
- Clostridium difficile
Chapter 67: Penicillins
- First through fourth generation penicillins
- Aztreonam – monobactam
Chapter 68: Carbapenems
- Indications
- Adverse Effects
- Imipenem/Cilastatin
- Meropenem
- Ertapenem
- Imipenem/Cilastatin/Relebactam
Chapter 69: Cephalosporins
- First through fifth generation
- Indications
- Administration
- Adverse Effects
Chapter 70: Introduction to Glycopeptides
- Antibiotic resistance
- Intravenous antibiotic administration systems
- Clostridium difficile
Chapter 71: Vancomycin
- Indications
- Administration
- Side effects
Chapter 72: Daptomycin
- Indications
- Administration
- Side effects
Chapter 73: Televancin
- Indications
- Administration
- Side effects
Chapter 74: Dalbavancin
- Indications
- Administration
- Side effects
Chapter 75: Oritavancin
- Indications
- Administration
- Side effects
Chapter 76: Teicoplanin
- Polymixins
- Peptide Antibiotic Pipeline
Chapter 77: Additional Classifications of Antibiotics
- Antibiotic resistance
- Intravenous antibiotic administration systems
- Clostridium difficile
Chapter 78: Aminoglycosides
- Indications
- Dosing and administration
- Adverse effects
Chapter 79: Fluorquinolones
- Class Adverse Effects
- Ciprofloxicin
- Delafloxacin
- Moxifloxicin
- Levofloxicin
- Clinical Trials
Chapter 80: Licosamides, Macrolides, Oxazolidones, and Streptogramins
- Lincomycin
- Clindamycin
- Azithromycin
- Erythromycin
- Linezolid
- Tedizolid
- Oxazolidone clinical trials
- Quinupristin/dalfopristin
Chapter 81: Tetracyclines
- Doxycycline
- Eravacycline
- Omadacycline
- Tigecycline
- Clinical trials
Chapter 82: Antibiotic Stewardship
- New antibiotic initiative
- Financial challenges
- Clinical pipelines
- Phage therapy
- Nanoparticles
82: References
Price: $325.00
Contact Hours: 28
Course Author
Pamela Clark
Pamela Clark, CRNI, is an infusion nurse with the Houston Methodist Sugar Land Hospital. She has more than 35 years of experience in infusion therapy and infusion education with both licensed nurses and patients. Her experience spans multiple infusion settings including: acute care, long-term care, home infusion, and ambulatory infusion care. She also has experience in oncology and oncology research.
Read Full Bio